podcast

Patients

The cardio-renal-metabolic space and obesity as a chronic di...

The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.

R&D

pharmaphorum podcast Episode 259, Cedrik Britten, Immatics

On the power of T-cells, with Cedrik Britten

Dr Cedrik Britten, chief medical officer at Immatics, discusses novel PRAME-directed T-cell immunotherapies.

Sales & Marketing

pharmaphorum podcast Episode 257, John Holodnak, Occam

A philosophical look at market turn in the Age of AI, with J...

John Holodnak, co-founder of Occam, discusses how AI is beginning to reshape career paths across life sciences.

Patients

pharmaphorum podcast Episode 256, Dean Erhardt, D2 Solutions

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

Sales & Marketing

Pushing through barriers to commercial launch success, with ...

In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.

Patients

pharmaphorum podcast Episode 254, Thomas Goetz, Drug Story

Every drug is a story, with Thomas Goetz

Thomas Goetz, creator and host of the Drug Story podcast on recognising pharmaceutical medicine as the socially and morally complex market that it is.

The cardio-renal-metabolic space and obesity as a chronic di...

On the power of T-cells, with Cedrik Britten

A philosophical look at market turn in the Age of AI, with J...

Providing patient access to new therapies, with Dean Erhardt

Pushing through barriers to commercial launch success, with ...

Every drug is a story, with Thomas Goetz

As Ebola deaths climb, search begins for vaccine

Discover a new era of healthcare panel engagement: Grounded ...

podcast

Editor's Picks